Series B Life Science Companies

Prolific Machines unlocks production of next-generation therapeutics with a light-controlled gene expression system and closed-loop control.

Sware provides validation automation platform and managed services programs.

Enifer is a mycoprotein company that produces a fungal fermentation product to upcycle agrifood industry byproducts.

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

Elegen is a biotechnology company that develops microfluidic technology.

DOT Compliance delivers the industry's first ready to use cloud-based quality and compliance management solution for regulated industries.

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.

Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

Othram aims to revolutionize how forensic cases are solved, justice is served, and families are mended.

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.

STALICLA is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.

Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine.

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

Polymateria is a startup advancing science to help nature deal with plastic pollution.

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

InDevR develops and manufactures microarray technologies as well as novel solutions to support the life science industry.

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.